Annual Interest Expense
$3.42 M
-$753.00 K-18.06%
December 31, 2023
Summary
- As of February 8, 2025, AVTX annual interest expense is $3.42 million, with the most recent change of -$753.00 thousand (-18.06%) on December 31, 2023.
- AVTX annual interest expense is now -18.06% below its all-time high of $4.17 million, reached on December 31, 2022.
Performance
AVTX Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Interest Expense
N/A
September 30, 2024
Summary
- AVTX quarterly interest expense is not available.
Performance
AVTX Quarterly Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM Interest Expense
N/A
September 30, 2024
Summary
- AVTX TTM interest expense is not available.
Performance
AVTX TTM Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Interest Expense Formula
Interest Expense = Carrying Value of Debt X Effective Interest Rate
AVTX Interest Expense Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -18.1% | - | - |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
AVTX Interest Expense Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -18.1% | +42.9% | ||||
| 5 y | 5-year | -18.1% | +42.9% | ||||
| alltime | all time | -18.1% | +42.9% |
Avalo Therapeutics Interest Expense History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | $3.42 M(-18.1%) | - | - |
| Mar 2023 | - | $949.00 K(0.0%) | $3.95 M(-5.3%) |
| Dec 2022 | $4.17 M | $949.00 K(+5.7%) | $4.17 M(-5.3%) |
| Sep 2022 | - | $898.00 K(-22.2%) | $4.41 M(-1.9%) |
| Jun 2022 | - | $1.15 M(-1.3%) | $4.49 M(+25.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $1.17 M(-1.3%) | $3.58 M(+48.5%) |
| Dec 2021 | $2.39 M | $1.18 M(+20.2%) | $2.41 M(+96.7%) |
| Sep 2021 | - | $985.00 K(+312.1%) | $1.22 M(+412.1%) |
| Jun 2021 | - | $239.00 K(>+9900.0%) | $239.00 K(>+9900.0%) |
| Sep 2020 | - | $0.00 | $0.00 |
FAQ
- What is Avalo Therapeutics annual interest expense?
- What is the all time high annual interest expense for Avalo Therapeutics?
- What is Avalo Therapeutics annual interest expense year-on-year change?
- What is the all time high quarterly interest expense for Avalo Therapeutics?
- What is the all time high TTM interest expense for Avalo Therapeutics?
What is Avalo Therapeutics annual interest expense?
The current annual interest expense of AVTX is $3.42 M
What is the all time high annual interest expense for Avalo Therapeutics?
Avalo Therapeutics all-time high annual interest expense is $4.17 M
What is Avalo Therapeutics annual interest expense year-on-year change?
Over the past year, AVTX annual interest expense has changed by -$753.00 K (-18.06%)
What is the all time high quarterly interest expense for Avalo Therapeutics?
Avalo Therapeutics all-time high quarterly interest expense is $1.18 M
What is the all time high TTM interest expense for Avalo Therapeutics?
Avalo Therapeutics all-time high TTM interest expense is $4.49 M